azasetron · adult cancer patients at risk for CINV caused by moderately emetogenic chemotherapy
1 finding from 1 review
casopitant + ondansetron · adult cancer patients at risk for CINV caused by moderately emetogenic chemotherapy
1 finding from 1 review
ondansetron · adult cancer patients at risk for CINV caused by moderately emetogenic chemotherapy
1 finding from 1 review
Interventions (corticosteroids included in all regimens)a · adult cancer patients at risk for CINV caused by moderately emetogenic chemotherapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
rolapitant + granisetron · adult cancer patients at risk for CINV caused by moderately emetogenic chemotherapy
1 finding from 1 review
Participant‐reported pain relief of 30% or greater · adults with neuropathic pain
It is very uncertain whether herbal treatment changes participant‐reported pain relief of 30% or greater Immediately… compared with placebo (very low certainty).
1 finding from 1 review
Participant‐reported pain relief of 50% or greater · adults with neuropathic pain
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Any pain‐related outcome indicating some improvement · adults with neuropathic pain
1 finding from 1 review
Study withdrawals Post‐intervention · adults with neuropathic pain
It is very uncertain whether herbal treatment changes study withdrawals Post‐intervention compared with placebo (very low certainty).
1 finding from 1 review
Adverse events Post‐intervention · adults with neuropathic pain
It is very uncertain whether herbal treatment changes adverse events Post‐intervention compared with placebo (very low certainty).
1 finding from 1 review
Migraine frequency Number of attacks · adults with migraine
1 finding from 1 review
Responder rate (achievement of at least 50% reduction in migraine frequency) Higher numbers mean more people responded · adults with migraine
It is very uncertain whether psychological therapies changes responder rate (achievement of at least 50% reduction in migraine… compared with controls (very low certainty).
1 finding from 1 review
Migraine intensityc Lower numbers = lower migraine intensity · adults with migraine
1 finding from 1 review
Migraine‐related disabilitye Lower numbers = lower reported migraine‐related disability · adults with migraine
1 finding from 1 review
Number of participants reporting an adverse event · adults with migraine
It is very uncertain whether psychological therapies changes adverse events (proportion of people reporting an adverse event)… compared with controls (very low certainty).
1 finding from 1 review
Number of migraine days per month: chronic migraine only · adults with migraine
1 finding from 1 review
Migraine frequency Number of attacks · adults with migraine
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Headache intensity (mean score) · adults with migraine
1 finding from 1 review
Number experiencing adverse effects · adults with migraine
It is very uncertain whether botulinum toxin type A changes total number of participants experiencing an adverse event compared with other established prophylactic agent (very low certainty).
1 finding from 1 review
Number of migraine days per month · adults with migraine
1 finding from 1 review